Reasons for the persistent incidence of venous thromboembolism

Summary

Reasons for trends in venous thromboembolism (VTE) incidence are uncertain. It was our objective to determine VTE incidence trends and risk factor prevalence, and estimate population-attributable risk (PAR) trends for each risk factor. In a population-based cohort study of all residents of Olmsted County, Minnesota from 1981–2010, annual incidence rates were calculated using incident VTE cases as the numerator and age- and sex-specific Olmsted County population estimates as the denominator. Poisson regression models were used to assess the relationship of crude incidence rates to year of diagnosis, age at diagnosis, and sex. Trends in annual prevalence of major VTE risk factors were estimated using linear regression. Poisson regression with time-dependent risk factors (person-years approach) was used to model the entire population of Olmsted County and derive the PAR. The age- and sex-adjusted annual VTE incidence, 1981–2010, did not change significantly. Over the time period, 1988–2010, the prevalence of obesity, surgery, active cancer and leg paresis increased. Patient age, hospitalisation, surgery, cancer, trauma, leg paresis and nursing home confinement jointly accounted for 79 % of incident VTE; obesity accounted for 33 % of incident idiopathic VTE. The increasing prevalence of obesity, cancer and surgery accounted in part for the persistent VTE incidence. The PAR of active cancer and surgery, 1981–2010, significantly increased. In conclusion, almost 80 % of incident VTE events are attributable to known major VTE risk factors and one-third of incident idiopathic VTE events are attributable to obesity. Increasing surgery PAR suggests that concurrent efforts to prevent VTE may have been insufficient.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Venous thrombosis - pulmonary embolism - thrombophlebitis - phlebitis - epidemiology

• References

• 1 The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Public Health Service 2008. U. S. Department of Health and Human Services. 2008
• 2 Shojania K, Duncan B, McDonald K-SU, Wachter R. Making Health Care Safer: A Critical Analysis of Patient Safety Practices: UCSF-Stanford Evidence-Based Practice Center, Agency for Healthcare Research and Quality, July 20, 2001Publication no. 01-E058, Evidence report no. 43. www.ahrq.gov/clinic/ptsafety/summary/htm 2001
• 3 Kahn SR, Lim W, Dunn AS. et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidellines.. Chest 2012; 141: e195S-226S.
• 4 Gould MK, Garcia DA, Wren SM. et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidellines.. Chest 2012; 141: e227S-277S.
• 5 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidellines.. Chest 2012; 141: e278S-325S.
• 6 Naess IA, Christiansen SC, Romundstad P. et al. Incidence and mortality of venous thrombosis: A population-based study.. J Thromb Haemost 2007; 05: 692-699.
• 7 DeMonaco NA, Dang Q, Kapoor WN, Ragni MV. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 2008; 121: 611-617.
• 8 Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: Evidence of overdiagnosis. Arch Intern Med 2011; 171: 831-837.
• 9 Tagalakis V, Wharin C, Kahn SR. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients. Semin Thromb Hemost 2013; 39: 127-140.
• 10 Huang W, Goldberg RJ, Anderson FA. et al. Secular trends in occurrence of acute venous thromboembolism: The Worcester VTE Study (1985–2009).. Am J Med 2014; 127: 829-839 e825..
• 11 Melton L. History of the Rochester Epidemiology Project. Mayo Clinic Proc 1996; 71: 266-274.
• 12 St Sauver JL, Grossardt BR, Yawn BP. et al. Use of a medical records linkage system to enumerate a dynamic population over time: The Rochester Epidemiology Project.. Am J Epidemiol 2011; 173: 1059-1068.
• 13 St Sauver JL, Grossardt BR, Leibson CL. et al. Generalizability of epidemiological findings and public health decisions: An illustration from the Rochester Epidemiology Project.. Mayo Clinic Proc 2012; 87: 151-160.
• 14 Silverstein MD. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study.. Arch Intern Med 1998; 158: 585-593.
• 15 Heit JA, Melton LJ, 3rd Lohse CM. et al. Incidence of venous thromboembolism in hospitalized patients vs community residents.. Mayo Clinic Proc 2001; 76: 1102-1110.
• 16 Heit JA. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost 2005; 03: 1611-1617.
• 17 Kurland LT, Molgaard CA. The patient record in epidemiology. Scientific American 1981; 245: 54-63.
• 18 Ashrani AA, Gullerud RE, Petterson TM. et al. Risk factors for venous thromboembolism among active cancer patients: a population-based case-control study.. Thromb Res 2016; 139: 29-37.
• 19 Heit JA, Silverstein MD, Mohr DN. et al. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study.. Arch Intern Med 2000; 160: 809-815.
• 20 Cramér H. Mathematical methods of statistics. Princeton, NJ; Princeton University Press: 1946: p.353
• 21 Heit JA, Leibson CL, Ashrani AA. et al. Is diabetes mellitus an independent risk factor for venous thromboembolism?: A population-based case-control study.. Arterioscl Thromb Vasc Biol 2009; 29: 1399-1405.
• 22 Spencer FA, Gore JM, Reed G. et al. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost 2009; 101: 878-885.
• 23 Cushman M, Tsai AW, White RH. et al. Deep vein thrombosis and pulmonary embolism in two cohorts: The Longitudinal Investigation of Thromboembolism Etiology.. Am J Med 2004; 117: 19-25.
• 24 Palareti G. How I treat isolated distal deep vein thrombosis (IDDVT). Blood 2014; 123: 1802-1809.
• 25 Heit JA, Silverstein MD, Mohr DN. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study.. Arch Intern Med 1999; 159: 445-453.
• 26 Ahronheim JC, Bernholc AS, Clark WD. Age trends in autopsy rates. Striking decline in late life. J Am Med Assoc 1983; 250: 1182-1186.
• 27 Hoyert DL. The changing profile of autopsied deaths in the United States, 1972–2007. NCHS Data Brief 2011; 1-8.
• 28 Stein PD, Matta F, Dalen JE. Is the campaign to prevent VTE in hospitalized patients working?. Chest 2011; 139: 1317-1321.
• 29 Burge AJ, Freeman KD, Klapper PJ, Haramati LB. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol 2008; 63: 381-386.
• 30 Leibson CL, Needleman J, Buerhaus P. et al. Identifying in-hospital venous thromboembolism (VTE): A comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort.. Med Care 2008; 46: 127-132.
• 31 Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. J Am Med Assoc 2012; 307: 1433-1435.
• 32 Haut ER, Pronovost PJ, Schneider EB. Limitations of administrative databases. J Am Med Assoc 2012; 307 2589 author reply 2589-2590.
• 33 Ashrani AA, Heit JA. Caution on interpreting the time trends in pulmonary embolism as "overdiagnosis". Arch Intern Med 2011; 171 1962 author reply 1962-1963.
• 34 Delluc A, Mottier D, Le Gal G. et al. Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study.. J Thromb Haemost 2009; 07: 728-729.